Cardiac consequences of malignancy and their treatment.
D000903:Antibiotics, Antineoplastic / Q000009:adverse effects; D000970:Antineoplastic Agents / Q000009:adverse effects*; D003520:Cyclophosphamide / Q000009:adverse effects; D005472:Fluorouracil / Q000009:adverse effects; D006321:Heart / Q000187:drug effects* / Q000528:radiation effects*; D006338:Heart Neoplasms / Q000175:diagnosis* / Q000556:secondary / Q000628:therapy; D006394:Hemangiosarcoma / Q000175:diagnosis / Q000628:therapy; D006801:Humans; D009232:Myxoma / Q000175:diagnosis / Q000628:therapy; D009279:Naphthacenes / Q000009:adverse effects; D011878:Radiotherapy / Q000009:adverse effects*; D012208:Rhabdomyosarcoma / Q000175:diagnosis / Q000628:therapy
D000903:Antibiotics, Antineoplastic; D000970:Antineoplastic Agents; D009279:Naphthacenes; D003520:Cyclophosphamide; D005472:Fluorouracil